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Recognition of Plasmodium falciparum 
mature gametocyte-infected erythrocytes 
by antibodies of semi-immune adults 
and malaria-exposed children from Gabon
Tamirat Gebru1,2,3,4,5, Anthony Ajua1,2, Michael Theisen6,7, Meral Esen1,2,3,4, Ulysse Ateba Ngoa1,2,3,4,8, 
Saadou Issifou1,2,9, Ayola A. Adegnika1,2,3,4,8, Peter G. Kremsner1,2,3,4, Benjamin Mordmüller1,2,3,4 
and Jana Held1,2,3,4*
Abstract 
Background: Transmission of malaria from man to mosquito depends on the presence of gametocytes, the sexual 
stage of Plasmodium parasites in the infected host. Naturally acquired antibodies against gametocytes exist and 
may play a role in controlling transmission by limiting the gametocyte development in the circulation or by inter-
rupting gamete development and fertilization in the mosquito following ingestion. So far, most studies on antibody 
responses to sexual stage antigens have focused on a subset of gametocyte-surface antigens, even though inhibitory 
Ab responses to other gametocyte antigens might also play a role in controlling gametocyte density and fertility. 
Limited information is available on natural antibody response to the surfaces of gametocyte-infected erythrocytes.
Methods: Ab responses to surface antigens of erythrocytes infected by in vitro differentiated Plasmodium falciparum 
mature gametocytes were investigated in sera of semi-immune adults and malaria-exposed children. In addition, 
the effect of immunization with GMZ2, a blood stage malaria vaccine candidate, and the effect of intestinal helminth 
infection on the development of immunity to gametocytes of P. falciparum was evaluated in malaria-exposed chil-
dren and adults from Gabon. Serum samples from two Phase I clinical trials conducted in Gabon were analysed by 
microscopic and flow-cytometric immunofluorescence assay.
Results: Adults had a higher Ab response compared to children. Ab reactivity was significantly higher after fixation 
and permeabilization of parasitized erythrocytes. Following vaccination with the malaria vaccine candidate GMZ2, 
anti-gametocyte Ab concentration decreased in adults compared to baseline. Ab response to whole asexual stage 
antigens had a significant but weak positive correlation to anti-gametocyte Ab responses in adults, but not in chil-
dren. Children infected with Ascaris lumbricoides had a significantly higher anti-gametocyte Ab response compared to 
non-infected children.
Conclusion: The current data suggest that antigens exposed on the gametocyte-infected red blood cells are recog-
nized by serum antibodies from malaria-exposed children and semi-immune adults. This anti-gametocyte immune 
response may be influenced by natural exposure and vaccination. Modulation of the natural immune response to 
gametocytes by co-infecting parasites should be investigated further and may have an important impact on malaria 
control strategies.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Malaria remains a major global public health problem 
affecting hundreds of millions of people annually, mainly 
in sub-Saharan Africa. Each year approximately half a 
million people die, mostly children younger than 5 years 
[1]. Gametocytes, the sexual stage of the parasites, are 
essential for transmission of the parasite from man to 
mosquito. Malaria transmission can be interrupted by 
drug treatment affecting gametocytes [2, 3], causal chem-
oprophylaxis, vector control as well as the acquisition of 
immunity to sexual stage parasites by the human host [4, 
5].
Transmission blocking interventions that target game-
tocyte development and gamete fertilization are con-
sidered an essential part of malaria control, especially 
if containment or eradication of the disease is the aim. 
Transmission blocking vaccines (TBVs) would have a 
great public benefit in malaria-endemic countries by 
breaking the life cycle and decreasing the number of new 
infections. In addition, it is assumed that TBVs could 
help in containing the spread of parasites resistant to 
drugs or malaria vaccine components directed against 
asexual blood stage or pre-erythrocytic stages [6, 7]. To 
better understand immunity against the sexual stage of 
the plasmodial life cycle and for the design and develop-
ment of TBVs, profiling the response to mature gameto-
cytes is of relevance.
Antibodies (Abs) are important mediators of sexual 
stage immunity against Plasmodium and other apicompl-
exan parasites [8–12]. Such Abs can affect malaria trans-
mission either by inhibiting gametocyte development [5] 
or by directly affecting viability of mature sexual stages 
[13–15]. The latter might happen within the body or once 
they are ingested by mosquitoes [5, 16–18], e.g. through 
opsonization of gametes followed by phagocytosis [12]. 
In malaria-endemic areas, the age-dependent decline of 
the duration of gametocyte carriage [19, 20] is most likely 
due to an increase in gametocyte exposure and develop-
ment of sexual stage specific immune responses, in paral-
lel to the asexual immunity acquired with age [21].
Indirectly, immune responses to asexual stage anti-
gens may decrease transmission by limiting the number 
of asexual parasites that develop to gametocytes [21], 
similar to the decrease of gametocytogenesis that results 
from the elimination of asexual infections by drugs [22]. 
However, development of sexual-stage immunity is dif-
ferent from the immune response directed to asexual 
stage antigens [13, 15]. Gametocytes have distinct gene 
expression patterns [23] and proteomic profiles [24] 
compared to asexual stages. Similarly early and late stage 
gametocytes differ; for example, the latter have a com-
paratively low representation of active export machinery 
proteins. However, some overlaps are expected in the 
proteomic profiles and exported proteins between the 
different stages of the parasite’s life cycle [24].
Naturally acquired sexual-stage antibodies are pro-
duced against gametocyte-infected erythrocyte surface 
antigens or gamete-specific antigens in the circulation 
and also against mosquito-stage parasites that act follow-
ing ingestion of the parasite [25]. There are only few stud-
ies on natural immune responses to gametocyte-infected 
erythrocyte surface antigens. Saeed et  al. [15] showed 
that 34% of Gambian children had plasma antibodies 
recognizing stage V gametocyte-infected erythrocytes 
in vitro, with no recognition of stages I–IV. In the same 
study Abs to gametocyte surface antigens were associated 
with lower gametocyte densities indicating the impor-
tance of Abs in reducing gametocyte carriage. Most other 
studies on immune responses to sexual stage antigens 
have focused on few specific antigens, mainly the TBV 
candidates Pfs230 [18, 26–31] and Pfs48/45 [18, 27–32]. 
The association of Ab response to these single antigens 
and transmission reducing activity is not consistent. 
After testing antibody response to both antigens, some 
authors reported a correlation of transmission reduction 
with both antigens [31], while others found associations 
only with Pfs230 [18, 28] or only with Pfs48/45 [29, 30]. 
Even though correlation might be confounded by expo-
sure history to earlier malaria infections, these results 
suggest that Ab responses to other gametocyte-specific 
antigens may play an additional role in controlling trans-
mission [5]. Here, Ab responses to gametocyte-infected 
erythrocyte surface antigens were measured in individu-
als from a malaria-endemic country (Gabon).
In the present study, the concentration of anti-game-
tocyte Abs against in  vitro differentiated mature game-
tocytes of one Plasmodium falciparum clinical isolate 
and one laboratory strain (NF54) was measured by flow 
cytometric immunofluorescence assay (IFA) in sera from 
malaria-exposed children and semi-immune adults. Since 
exposure to asexual blood stage antigens and co-infec-
tion with other highly prevalent parasites may modulate 
immune responses [33, 34], here the anti-gametocyte 
responses were related to infection status with intestinal 
helminths. Assuming a reduced anti-gametocyte anti-
body response after vaccination with a malarial vaccine, 
Keywords: Malaria, Transmission blocking, Plasmodium falciparum, Clinical isolates, Helminths, Ascaris lumbricoides, 
Trichuris trichiura, GMZ2, Immune modulation
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additionally the anti-gametocyte antibody response to 
antibodies induced by vaccination was related with the 
asexual blood stage vaccine candidate GMZ2, a recombi-
nant fusion protein of P. falciparum glutamate-rich pro-
tein (GLURP) and merozoite surface protein 3 (MSP3) 
[35]. Therefore, the collected serum samples during the 
GMZ2 trials were used to investigate this in depth.
Methods
Study samples and sources
Gametocyte recognition of antibodies were investigated 
in adults and children who had a different history of 
exposures to malaria and infection status with intestinal 
helminths. The serum samples analysed in the current 
investigation are from two studies [36, 37] conducted 
between July 2007 and October 2008 at the Centre de 
Recherches Médicales de Lambaréné (CERMEL), Lam-
baréné in Gabon. The two sets of serum samples were 
from Phase I clinical trials designed to assess safety and 
immunogenicity of GMZ2, an experimental blood-stage 
malaria vaccine candidate, in malaria-exposed adults and 
children, respectively [36, 37], which shows partial effi-
cacy [38].
As part of the GMZ2 trials, samples were collected 
from 30 children aged 1–5  years [36] and 40 semi-
immune adults (18–45  years) [37]. At the time of this 
investigation samples were only available for 36 adults. 
Samples collected before (Day 0) and on Day 84 after 
vaccination (4  weeks after the last immunization) were 
analysed to assess if vaccination has an effect on the 
development of antibody response to the sexual stages 
of P. falciparum. During the GMZ2 trials, participants 
received three doses of either 30 or 100 μg GMZ2, adju-
vanted with aluminum hydroxide or a control vaccine 
(Verorab) and were followed for 1 year. Further details of 
the studies are published elsewhere [36, 37]. Serum sam-
ples were stored at −80 °C until analysed.
The studies were conducted according to the principles 
of the Declaration of Helsinki and good clinical prac-
tice guidelines. The respective competent ethics com-
mittees: the Comité d’Ethique Régional Indépendant de 
Lambaréné, CERIL and the Gabonese Ministry of Health 
reviewed and approved the studies. A signed informed 
consent was obtained from each participant or parent/
guardian of participant aged less than 18 years. Analysis 
of Ab levels against P. falciparum was part of the respec-
tive study protocols.
Gametocyte culture and purification
Gametocyte culture was initiated from a continuous 
culture of asexual P. falciparum parasites as described 
earlier [39]. Briefly, the asexual cultures were kept at 5% 
haematocrit and less than 2% parasitaemia at 37  °C, 5% 
 CO2 and 5%  O2 with weekly sorbitol synchronization and 
daily change of medium (RPMI 1640 supplemented with 
25 mM HEPES, 28 mM  NaHCO3, 50 μg/mL gentamycin, 
0.5% w/v Albumax II, 2.4 mM l-glutamine, and 0.14 mM 
hypoxanthine); medium of the clinical isolate contained 
in addition 5% human serum. The P. falciparum labora-
tory strain NF54 (Sanaria Inc., Rockville, MD, USA) and 
a laboratory adapted clinical isolate from Lambaréné, 
Gabon where the samples had been collected were used 
for the experiments. The clinical isolate (JH013) was cul-
tivated from a blood sample collected in 2009 from an 
individual with P. falciparum mono-infection and cryo-
preserved at −150  °C in glycerolyte as reported previ-
ously [40].
Gametocyte culture was performed as described ear-
lier [41, 42] with some modifications. Human serum 
(5%) was added to the gametocyte growth media and the 
culture was initiated with a parasitaemia of 0.5 and 9% 
haematocrit and kept at 5%  O2/CO2 at 37  °C with daily 
change of medium without parasite dilution. On Day 
7 the haematocrit was lowered to 4.5% by doubling the 
volume of medium. Beginning with Day 11 the parasites 
were treated with 50  mM N-acetyl-d-glucosamine (MP 
Biomedicals GmbH, Santa Ana, CA, USA) for 4 days to 
eliminate asexual stage parasites.
To enrich stage V gametocytes from approximately 2% 
to more than 90% on Day 15 a density gradient centrifu-
gation (800g for 20  min) on 33% NycoPrep 1.077 cush-
ions (AXIS-SHIELD PoC AS, Oslo, Norway) followed by 
magnetic separation with LD-MACS magnetic columns 
(Miltenyi Biotec, Gladbach, Germany) was performed.
Fluorescence microscopy and flow cytometry‑based IFA
For IFA, gametocyte-infected erythrocytes were analyzed 
in three different ways: live [15], fixed, or fixed and per-
meabilized [43]. For assessment of Ab response to plas-
modial antigens, a P. falciparum culture was used, that 
was enriched for late developmental stages of asexual 
[44] and stage V gametocytes. In brief, for fixation, para-
sites were incubated for 30 min in a mixture of 4% Elec-
tron Microscopy (EM) grade paraformaldehyde (Merck, 
Germany) and 0.0075% EM grade glutaraldehyde (Sigma-
Aldrich, Germany), then washed once with PBS and 
stored at 4  °C until the IFA was performed. Prior to Ab 
staining, a fraction of fixed cells was permeabilized by 
PBS/0.1% Triton-X-100 for 10 min and washed once with 
PBS.
All live, fixed or fixed and permeabilized parasites were 
blocked using PBS/3%BSA for 1 h before the addition of 
test or negative control sera. Following the blocking step, 
evaluation of anti-gametocyte Ab response was done 
using cytometry-based IFA as described earlier [44]. 
Serum samples (in PBS/3% BSA diluted 1/4000 and 1/50, 
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respectively) from adults and children were added and 
incubated for 1 h. Serum dilutions that gave the best dis-
crimination between negative and positive were used. In 
the cohort children are less reactive compared to adults, 
hence lower dilutions were used [45, 46]. After three 
washes with PBS, secondary Ab staining was carried out 
for 1  h with Alexa Fluor 488-labeled rabbit anti-human 
IgG (Life Technologies GmbH, Darmstadt, Germany) at a 
1:3000 dilution and washed three times before the quality 
of the staining was assessed by fluorescence microscopy.
Subsequent acquisition of flow cytometry data was 
done using a FACSCanto II cytometer equipped with the 
FACSDiva software version 6.1.2 (BD Biosciences, San 
Jose, USA). Fluorescence of each event was analysed and 
the result expressed as percentage of positive fluores-
cent cells (PPFC) based on 20,000 erythrocytes (events) 
acquired.
ELISA for measurement of Abs to GMZ2 antigens
For comparison, a subset of previously reported GMZ2-
specific IgG ELISA values (Days 0 and 84) of clinical trial 
participants were used for the current analyses [36, 37]. 
ELISA data were generated using a standardized ELISA 
protocol as described previously [36, 37].
Stool examination for worm infection
During follow up of study participants enrolled in the 
Phase I paediatric clinical trial of GMZ2 [36], stool 
samples were collected. They were freshly examined to 
evaluate the prevalence of soil-transmitted helminths at 
enrolment and on Day 84 as reported earlier [34].
Statistical analysis
GraphPad Prism version 5.0 (GraphPad Software, San 
Diego California) and SPSS version 16 were used for sta-
tistical analysis. Nonparametric tests were used for statis-
tical testing. The significance level was set to a two-sided 
alpha of 0.05 and corrected using the Bonferroni method 
where applicable. Paired samples were tested with the 
Wilcoxon signed-rank test whereas the Mann–Whit-
ney test was applied in case of unpaired data. Spearman 
correlation between Ab responses to whole sexual and 
asexual stage (including recombinant GMZ2) antigens 
were calculated and presented with 95% confidence 
intervals [47]. A sample was declared sero-negative by 
cytometric IFA if the percentage gated cells positive for a 
given marker was within three standard deviations above 
the mean of the negative controls (serum samples from 
malaria naïve individuals).
Results
Recognition of gametocyte antigens by Abs is enhanced 
by fixation and permeabilization
The level and prevalence of Ab response to P. falciparum 
mature gametocytes was evaluated in sera from adults 
(n = 36) and children (n = 30) from the two GMZ2 tri-
als (Table 1) using live, fixed or fixed and permeabilized 
NF54 P. falciparum mature gametocyte infected eryth-
rocytes. As expected, the level of antigen recognition by 
Abs was significantly higher after fixation and permea-
bilization of NF54 P. falciparum gametocyte-infected 
erythrocytes, two-fold and four-fold change, respectively 
(Fig. 1). Apparently, immune recognition of the parasite 
includes antigens not expressed on the surface of eryth-
rocytes (Fig. 2a, b). However, these intracellular antigens 
could also be shared by the asexual and sexual antigens of 
the parasite. Therefore, for all subsequent measurements, 
Table 1 Study name, background characteristics, grouping, hematological profiles and time of data collection of samples 
used within the study
Study identifier 
(population)
Sampling period 
(month/year)
No. of partici‑
pants
Median age 
in years (range)
Mean hemoglobin 
(g/dL)
Vaccine alloca‑
tion
Samples 
time points
GMZ2_3_08
(Children) [36]
09/2008–10/2009 30 3.5 (1–5) 10.5
10.5
10.3
GMZ2 100 µg
GMZ2 30 µg
Rabies
Days 0 and 84
GMZ2_2_07
(Adults) [37]
07/2007–08/2008 32 26.3 (18–45) 13.8
14.1
GMZ2 100 µg
Rabies
Days 0 and 84
Fig. 1 Antibody response to in vitro differentiated live, fixed or 
permeabilized Plasmodium falciparum gametocytes. The figure shows 
the flow cytometric data obtained using live, fixed or permeabi-
lized gametocyte-infected erythrocytes. Dots represent percentage 
positive cells (erythrocytes positive for AlexaFluor-488), one dot per 
tested sample. Gates were set against controls, which are serum from 
malaria naïve individuals. NF non fixed, NP non permeabilized, F fixed, 
P permeabilized. The Y-axis shows percentage of erythrocytes positive 
for the used marker (Alexa.Fluor-488)
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non-fixed and non-permeabilized gametocyte-infected 
erythrocytes were used.
Anti‑gametocyte Ab responses of malaria‑exposed 
individuals in different P. falciparum parasite strains
The anti-gametocyte Ab-binding patterns of one clini-
cal isolate (JH013) and NF54 were compared to identify 
the strain that is best recognized by participants’ Abs 
[37]. There was no significant difference between the 
two strains in the recognition of gametocytes by serum 
antibodies from adults and children of the studies and, 
therefore, further experiments were done only with the 
P. falciparum laboratory strain NF54. The Ab response 
to mature gametocytes was higher in adults compared 
to children (Fig.  3), as well as the seroprevalence of 
anti-gametocyte Ab response (77% in adults and 57% in 
children).
Asexual and sexual stage anti‑malarial immune response 
in GMZ2 vaccinated adults and children
The effect of GMZ2 vaccination on the development of 
anti-gametocyte immune response in adults and children 
was assessed. It was hypothesized that immune responses 
generated by the GMZ2 vaccine may divert the immune 
response towards the vaccine or lead to a lower gameto-
cyte density, despite its relatively low efficacy (11–14%) 
Fig. 2 Microscopic IFA of antibody response to P. falciparum gametocytes. The figures show an example picture of AlexaFluor-488 stained parasites 
by fluorescence microscopy before (a) and after (b) permeabilization
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in children between 1 and 5  years [38]. Interestingly, 
the anti-gametocyte Ab response in GMZ2 vaccinated 
adult individuals was lower on Day 84 after vaccination 
compared to baseline (Day 0) (Fig.  4a). In children, the 
anti-gametocyte Ab response was not different after vac-
cination in both, the GMZ2 and rabies vaccinated control 
group (Fig. 4b).
Since sexual stage immunity may be developed inde-
pendently from asexual-stage immunity [13, 15], possible 
associations were tested between sexual stage immune 
response (anti-gametocyte Abs) to the asexual stage 
immunity (Abs against asexual blood stages) and Ab 
responses to the GMZ2 vaccine antigen in the two vacci-
nated groups. For this analysis, our previously published 
data on anti-plasmodial (against whole asexual stage 
antigens) [44] and anti-GMZ2 [36, 37] Abs were used 
to assess correlations with anti-gametocyte Abs. There 
was a positive correlation on Day 0 before vaccination 
between the sexual and asexual Ab responses in the semi-
immune population (Table 2). No correlation was found 
in data from children. The Ab response to GMZ2 was not 
associated with sexual Ab response neither in adults nor 
in children (Table 2).
Effect of helminth infection on development 
of anti‑gametocyte immunity
The anti-plasmodial immune response is modulated 
by co-infection of P. falciparum with other infectious 
agents including helminths [48–50]. Previously an effect 
of intestinal helminths on anti-GMZ2 responses in 20 
GMZ2 vaccinated children was found [34] and, there-
fore, also in this study the effect of intestinal parasites co-
infection on the modulation of anti-gametocyte immune 
responses in children was assessed. Parasitological data 
of all 30 children included in the GMZ2 Phase Ib trial 
[36] were used to explore the modulation of anti-game-
tocyte immune response by helminths. Overall, five dif-
ferent helminths were recorded. Trichuris trichiura and 
Ascaris lumbricoides were present in a relative high pro-
portion on enrolment (14/30; 47% and 8/30; 27%) and on 
Day 84 (15/30; 50% and 11/30; 37%), respectively. There 
was also a low rate of infections (<7%) by Strongyloides, 
Fig. 3 Baseline levels of antibody response to gametocytes of P. 
falciparum in semi-immune adults and malaria exposed children. 
Antibody response (percentage of positive cells) against in vitro 
developed matured gametocytes (P. falciparum NF54 strain) of the 
serum samples of the different trials conducted in Gabon (GMZ2 
children on Day 0 [36] and GMZ2 adults on Day 0 [37]) at baseline. 
Median, 25th and 75th percentiles, and minimum and maximum 
ranges are indicated
Fig. 4 Effect of GMZ2 vaccination on the development of antibody response to mature P. falciparum gametocytes. a, b Show the antibody 
response in semi-immune adults and malaria-exposed children, respectively. In adults, 73.3% (11/15) show a decrease of Ab response after vac-
cination while 20% (3/15) show an increase and one person has shown no change (6.7%). D0 Day 0, D84 Day 84, GMZ2 100 µg or GMZ2 30 µg: 
participants who received 100 or 30 µg of GMZ2 vaccine, respectively. Rabies: participants who received the control rabies vaccine
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Schistosoma, and Ancylostoma. Interestingly, children 
infected with Ascaris lumbricoides had significantly 
higher anti-gametocyte Ab response compared to unin-
fected children when using live non-permeabilized 
gametocytes (Fig.  5a). When the assay was done using 
fixed and permeabilized parasites, a significantly lower 
Ab response was observed in Trichuris trichiura-infected 
children (Fig. 5b).
Discussion
Understanding the development of Ab responses to 
sexual stages of P. falciparum in malaria-exposed popu-
lations is important for understanding transmission 
patterns and the design and development of TBVs. In this 
study in a highly malaria endemic area, adults showed 
higher Ab responses to sexual stage antigens than chil-
dren. The effect of age on anti-gametocyte Ab production 
and transmission reducing activity has been addressed 
in several studies and resulted in contradictory results. 
Some have shown an increase in antibody response to 
fixed whole parasites [51] and to Pfs48/45 and Pfs230 
with age [46], others a decline in transmission reducing 
activity of sera with age [27]. The difference may be due to 
the varying age ranges, different epidemiological settings 
and inconsistent assays for anti-gametocyte Ab meas-
urements between the studies. Since effective humoral 
Table 2 Spearman correlation of  the antibody response to  sexual stage antigens with  asexual stage antigens and  the 
GMZ2 vaccine antigen of P. falciparum in adults/children from Gabon
C-IFA Cytometric immunofluorescence assay, ELISA Enzyme-linked immunosorbent assay, PPFC percent positive fluorescent cells, CI Confidence interval
Significant p value is indicated as follows: * P < 0.05
a  D0 Values represent both GMZ2 and Rabies groups together. D0 Day 0, D84 Day 84
Study participants and vaccination Antibody against whole asexual stage anti‑
gens by C‑IFA (Mean PPFC)
Antibody against GMZ2 
by ELISA (Mean Ab titers)
Rho (95% CI) Rho (95% CI)
Antibody against stage V gametocytes by C-IFA (Mean PPFC)
Adults
 D0a 0.39 (0.03, 0.66)* 0.17 (−0.18, 0.48)
 D84 (GMZ2) 0.41 (−0.17, 0.78) 0.44 (−0.13, 0.80)
 D84 (Rabies) 0.40 (−0.21, 0.79) 0.54 (−0.03, 0.85)
Children
 D0a 0.16 (−0.24, 0.51) 0.28 (−0.11, 0.60)
 D84 (GMZ2, 30 µg dose) 0.02 (−0.62, 0.64) −0.10 (−0.69, 0.57)
 D84 (GMZ2, 100 µg dose) 0.06 (−0.59, 0.67) 0.22 (−0.48, 0.75)
 D84 (Rabies) −0.27 (−0.77, 0.44) 0.22 (−0.48, 0.75)
Fig. 5 Antibody response to P. falciparum mature gametocytes in children from Gabon infected with intestinal parasites. The x-axis shows helminth 
infection status on Day 0 before vaccination in children, N = 30. a, b show antibody recognition of live and permeabilized gametocyte infected 
erythrocytes, respectively. Y-axis shows percentage of erythrocytes positive for AlexaFluor-488. PPFC  % positive fluorescent cells, IQR Interquartile 
range. Median and IQR are indicated
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immunity to intraerythrocytic gametocytes requires pro-
longed exposure to the parasite [52], the epidemiological 
setting shall play an important role and the interpretation 
of divergent results needs to account for that.
The anti-gametocyte seropositivity rate was 77% in 
adults and 57% in children. Similar seropositivity rates 
have been recorded earlier, more than 50% in Ghana-
ian children with asymptomatic infection [53] and 34% 
in Gambian children with uncomplicated malaria and 
gametocytaemia [15]. In another cohort of Gambian 
children, who were gametocytaemic, an Ab response 
was detected in all participants [51]. This response 
might have been so high, as they fixed gametocytes with 
acetone that simultaneously permeabilizes the cell [54]. 
The same study reported a lower (42%) sero-prevalence 
when live gametes were used. Unfortunately, gametocyte 
carriage rates were not recorded in our studies. Due to 
different methodologies, direct comparison to the pre-
viously reported results is not possible. Of note, game-
tocyte prevalence is not always associated to antibody 
response to gametocytes [55] and transmission capacity 
[56, 57].
The effect of anti-GMZ2 Ab and Ab responses to whole 
asexual stage antigens and the effect of GMZ2 vaccina-
tion on the development of sexual-stage immunity was 
evaluated. The result showed a significant but weak posi-
tive correlation between Ab response to gametocyte anti-
gens and whole asexual stage antigens, but not to GMZ2 
antigen in adults, showing that exposure is correlated to 
Ab response to gametocytes in the investigated popula-
tion. The level of sexual Ab response was significantly 
reduced after vaccination in GMZ2 vaccinated adults, 
but this difference was not seen in the rabies control 
group. An effective asexual malaria vaccine should lead 
to a reduced asexual parasite load and, therefore, reduced 
gametocyte production. The recently reported results of 
the GMZ2 vaccine shows 11–14% efficacy in children 
[38], therefore, the expected effect on gametocytes would 
be rather low. There is no evidence for the expression 
of either of the GMZ2 component proteins (MSP3 and 
GLURP) on the surface of gametocyte infected erythro-
cytes even though it was previously reported that GLURP 
is expressed in different stages of the parasite life cycle 
including the pre-erythrocytic stage [58]. The results 
show no boosting of the anti-gametocyte Ab response, 
supporting the data that none of the components is pre-
sent at the sexual stage.
In children, there was no correlation between the Ab 
response to gametocyte antigens and GMZ2 (and other 
asexual antigens). The difference of the correlation results 
between adults and children might be due to the very 
low level of anti-gametocyte immune response in chil-
dren complicating to see differences between groups. 
Additionally, Ab response to matured gametocytes did 
not change in children following vaccination with GMZ2 
or the rabies control vaccine. Unfortunately our analysis 
has been underpowered to detect subtle differences in 
the study populations. Our result shall be confirmed with 
a bigger sample size.
As expected, antigen recognition by immune sera was 
significantly enhanced after fixation and permeabiliza-
tion of gametocyte-infected erythrocytes as reported 
earlier [51]. This effect may be partly due to intracellu-
lar targets of transmission-blocking Abs [52] that are not 
exposed on the infected erythrocyte surface. However, 
the response measured after fixation and permeabiliza-
tion of cells might not be gametocyte specific, but rep-
resent a response to the cocktail of internal asexual and 
sexual stage proteins [59]. Therefore, non-fixed and non-
permeabilized gametocyte-infected erythrocytes were 
used to analyse the effect of age, vaccination, coinfection, 
and parasite strain variation on Ab responses to gameto-
cytes. The natural Ab response to gametocyte antigens 
might inhibit gametocyte development and thereby inter-
rupt the transmission of the parasite as shown in vitro by 
co-cultivation of early gametocytes with plasma from 
malaria patients [5]. In addition, Abs may also act follow-
ing exflagellation in the mosquito midgut [60]. To get a 
deeper insight, characterization of naturally acquired 
transmission blocking Abs might improve the portfolio 
of TBVs.
Recognition of P. falciparum gametocytes of the labora-
tory strain NF54 and a clinical isolate by serum antibod-
ies of semi-immune adults was assessed. Both lab strain 
and clinical isolate have been detected by the serum anti-
bodies and no significant difference in the level of Ab 
recognition of the two strains could be seen. This was 
unexpected as the clinical isolate was collected from the 
area where the study participants were recruited. How-
ever, similar to the finding presented here, it has been 
shown earlier by Dinko et al. that the plasma antibodies 
from Ghanian participants recognizing the laboratory 
strain 3D7 and a clinical isolate from Kenia [55].
The immune response to malaria is modulated by 
co-infection with other infectious agents [33]. There 
were lower Ab responses in Trichuris trichiura infected 
children when the assay was done with permeabilized 
gametocytes. However this might not represent the 
suppression of the immune response to gametocytes 
but rather the response to the asexual or both stages 
of the parasite. This corroborates earlier findings in the 
same population, which showed that Trichuris trichiura 
infection is associated with 3.4-fold reduced Ab lev-
els to the blood-stage asexual GMZ2 vaccine antigen 
while the response was increased in Ascaris lumbri-
coides-infected participants [34]. However, the effect 
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of Trichuris trichiura infection could not be seen in the 
assay using non-permeabilized gametocyte-infected 
erythrocytes. In line with this, a cross-sectional study 
has reported a significant reduction of gametocyte spe-
cific (Pfs48/45) antibody titers in individuals infected 
with Schistosoma haematobium, though this effect is 
not seen when comparing another gametocyte specific 
antigen (Pfs230) [61].
The response to any gamete-specific antigens was not 
measured and therefore activation of non-fixed gameto-
cytes cannot be ruled out. Mature gametocytes should 
be handled with care and a drop in temperature could 
provoke exflagellation. Therefore, the small fraction of 
recognized erythrocytes with gametocytes could also be 
a small fraction that was accidentally activated. However, 
we tried to ensure that non-fixed and non-permeabilized 
erythrocytes in the assay were intact and controlled for 
exflagellation by microscopy. Therefore, the measured 
response most probably represents largely the antibody 
response to antigens displayed on the surface of gameto-
cyte-infected erythrocytes. Another explanation for the 
low response could be that only a fraction of gametocytes 
transport proteins to the outside and express surface pro-
teins on the surface of erythrocytes. A reduced transport 
of proteins to the erythrocyte surface is known for asex-
ual parasites of laboratory strains in long-term culture. 
To check this, the prevalence of positive cells was tested 
also for one clinical isolate (JH013), but did not find a dif-
ference in the percentage of recognized cells when com-
pared to NF54.
Infection with Ascaris lumbricoides resulted in an 
increased anti-gametocyte immune response compared 
to the uninfected participants. This was surprising but 
similar effects on the anti-malarial immune response 
have been observed earlier [34]. However, due to the 
relatively small sample size and exploratory nature of the 
experiment, confirmatory studies will be required. There-
fore, monitoring of anti-gametocyte responses should 
be done in further larger studies. In addition, it would 
be interesting to validate the immuno-modulatory effect 
of co-infections on the development of asexual and sex-
ual stage immune responses and the transmissibility of 
malaria in other co-endemic areas.
Conclusions
The level of Ab responses to mature gametocytes can be 
measured using flow cytometry. Adults show higher Ab 
responses when compared to children. Anti-gametocyte 
Ab responses are enhanced following permeabilization 
but may include responses to asexual antigens. Helminth 
infections and anti-malarial interventions modulate the 
humoral immune response to asexual and sexual blood 
stage P. falciparum parasitaemia. This may have a signifi-
cant impact on malaria control strategies with the aim to 
reduce transmission of malaria.
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